The 3 analysts offering 1 year price forecasts for PHN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to PHN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PHN EPS for the last quarter is 0.44 EUR despite the estimation of 0.43 EUR. In the next quarter EPS is expected to reach 0.54 EUR. Track more of PHARMANUTRA financials and stay on top of what is up with the company.
In the next quarter PHARMANUTRA revenue is expected to reach 29.00 M EUR. Check out PHARMANUTRA revenue and earnings and make informed decisions.
According to analysts, PHN price target is 84.33 EUR with a max estimate of 88.00 EUR and a min estimate of 78.00 EUR. Check if this forecast comes true in a year, meanwhile watch PHARMANUTRA stock price chart and keep track of the current situation with PHN news and stock market news.